A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.

Eli Lilly said its drug Zepbound led to greater weight reduction than rival Novo Nordisk's Wegovy in a head-to-head randomized controlled trial.

England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to only a small proportion of the patients who could benefit from it.

Eli Lilly (LLY) stock is rising after the company said its weight-loss drug achieved better results than Wegovy

The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible, and alongside a specialized diet.